<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04873466</url>
  </required_header>
  <id_info>
    <org_study_id>FGC-20-004</org_study_id>
    <nct_id>NCT04873466</nct_id>
  </id_info>
  <brief_title>The Effects of Enzyme-rich Malt Extract on Chronic Constipation</brief_title>
  <official_title>The Effects of Enzyme-rich Malt Extract on Symptoms of Chronic Constipation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Functional Gut Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Functional Gut Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Participants with constipation will take enzyme-rich malt extract for 4 weeks whilst&#xD;
      completing a daily bowel habit diary before and during intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study is an open label, pre-post interventional study to evaluate the use of ERME&#xD;
      in the treatment of people with chronic constipation.&#xD;
&#xD;
      This study involves eligible participants that have a diagnosis constipation according to the&#xD;
      Knowles-Eccersley-Scott Score (KESS). Participants will receive intervention with a food&#xD;
      supplement enzyme-rich malt extract (ERME) at a dose of 15ml twice daily with food.&#xD;
&#xD;
      Before intervention commences, participants will complete baseline breath samples, quality of&#xD;
      life questionnaire (WHOQOL-BREF), and a 7 day stool diary to assess stool frequency and&#xD;
      consistency.&#xD;
&#xD;
      Participants will then receive the ERME as instructed and continue to complete a bowel diary.&#xD;
      Then at 4 weeks since starting the intervention, participants will provide another breath&#xD;
      sample and complete another breath samples and quality of life questionnaire (WHOQOL-BREF).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2021</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Prospective Cohort</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Open label, single arm</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in KESS (constipation)</measure>
    <time_frame>35 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Increase in stool frequency</measure>
    <time_frame>35 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in breath methane levels</measure>
    <time_frame>35 days</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Constipation</condition>
  <condition>Quality of Life</condition>
  <condition>Methane Production</condition>
  <arm_group>
    <arm_group_label>Enzyme-rich malt extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Enzyme-rich malt extract (15 ml b.i.d with food)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Enzyme-rich malt extract</intervention_name>
    <description>Enzyme-rich malt extract (ERME) is a by-product of the malting process in which the cereal grain barley is dried. The ingredients are 100% barley malt extract. It smells and tastes sweet, with a runny jam-like texture. Malt extract has been used as a food stuff in baking and cookery for many years, but ERME is extracted by means which retains more active enzymes, such as amylase.</description>
    <arm_group_label>Enzyme-rich malt extract</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participant has diagnosis of chronic constipation according to the KESS score.&#xD;
&#xD;
          -  Participant can communicate and understand English.&#xD;
&#xD;
          -  Participant has a body mass index (BMI) between 18.5 and 34.9kg/m2 (bounds included).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Dependant use of opioid-based medications.&#xD;
&#xD;
          -  New use of prokinetic therapy during the study.&#xD;
&#xD;
          -  Use of antibiotics in the last 4 weeks.&#xD;
&#xD;
          -  Use of probiotics in the last 2 weeks.&#xD;
&#xD;
          -  Organic gastrointestinal disease, including inflammatory bowel disease (IBD), coeliac&#xD;
             disease and diverticulitis.&#xD;
&#xD;
          -  Participant has known mechanical obstruction of the GI tract.&#xD;
&#xD;
          -  Participant has diabetes.&#xD;
&#xD;
          -  Participant has any hepatic disease.&#xD;
&#xD;
          -  Participant has any disease of the CNS.&#xD;
&#xD;
          -  Participant has had previous abdominal or colorectal surgery including appendectomy,&#xD;
             cholecystectomy, and hysterectomy.&#xD;
&#xD;
          -  Participant has intake of ERME for 2 weeks before the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Functional Gut Clinic</name>
      <address>
        <city>Manchester</city>
        <state>Greater Manchester</state>
        <zip>M2 4NG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordan Haworth, BSc</last_name>
      <phone>01613027777</phone>
      <email>jordan@functionalgutdiagnostics.com</email>
    </contact>
    <investigator>
      <last_name>Jordan J Haworth, BSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://functionalgutdiagnostics.com/clinical-research/</url>
    <description>Related Info</description>
  </link>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2021</study_first_posted>
  <last_update_submitted>April 30, 2021</last_update_submitted>
  <last_update_submitted_qc>April 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Functional Gut Clinic</investigator_affiliation>
    <investigator_full_name>Jordan Haworth</investigator_full_name>
    <investigator_title>Clinical Physiologist</investigator_title>
  </responsible_party>
  <keyword>Constipation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

